Mozobil (PLERIXAFOR)

**Product type:** Human Prescription Drug

**Active ingredient:** PLERIXAFOR

**Strength:** 24 mg/1.2mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** Sanofi-Aventis U.S. LLC

**Marketing category:** NDA (NDA022311)

**Pharmacologic class:** Hematopoietic Stem Cell Mobilizer [EPC], Increased Hematopoietic Stem Cell Mobilization [PE]